MUMBAI, India, Feb. 27 -- Intellectual Property India has published a patent application (202541130021 A) filed by M. Manisha; N. Prakash; Mi. Yasar Idhisham; R. Dhanush; E. Thirukumaran; R. Jagadesh; A. Lakmitha; C. Divya; M. Premkumar; and G. Devasree, Salem, Tamil Nadu, on Dec. 22, 2025, for 'cloud connected iot wearables for remote monitoring of hypertrophic cardiomyopathy.'
Inventor(s) include M. Manisha; N. Prakash; Mi. Yasar Idhisham; R. Dhanush; E. Thirukumaran; R. Jagadesh; A. Lakmitha; C. Divya; M. Premkumar; and G. Devasree.
The application for the patent was published on Feb. 27, under issue no. 09/2026.
According to the abstract released by the Intellectual Property India: "Hypertrophic cardiomyopathy (HCM) is a hereditary heart condition that needs ongoing monitoring owing to its link to arrhythmias and abrupt cardiac death. Traditional clinical monitoring systems are constrained by periodic examinations and lack real-time information 5 about patient conditions. A cloud-connected Internet of Things (IoT) wearable solution for remote monitoring of patients with HCMs.The proposed architecture uses wearable biosensors to continually gather physiological metrics including heart rate, ECG signals, and physical activity data. These data are safely sent to a cloud platform for storage, processing, and analysis. Cloud-based analytics provide real-time visualisation, automatic alarms, and 10 long-term trend analysis to aid in the early identification of aberrant cardiac events. The solution enables professionals to access data remotely, resulting in more prompt clinical decisions and personalised patient treatment. By providing continuous, non-invasive monitoring outside of hospital settings, the suggested approach intends to minimise hospital visits, improve early risk classification, and improve HCM patients' quality of life. The 15 findings show that cloud-connected IoT devices may be an effective and scalable solution to remote cardiac treatment."
Disclaimer: Curated by HT Syndication.
